Evidence map›Paper›PMID 35775387›Full record

ArticleTurkish journal of pharmaceutical sciences2022

Potentially Inappropriate Medication Use in Older Adults with Chronic Kidney Disease.

Aysel Pehlivanlı, Aysu Selçuk, Şahin Eyüpoğlu, Şehsuvar Ertürk, Arif Tanju Özçelikay

Open access · diamondAbstract read
In one paragraph

Article in Turkish journal of pharmaceutical sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Aysel PehlivanlıAnkara University, Faculty of Pharmacy, Department of Clinical Pharmacy, Ankara, Türkiye.ORCID 0000-0003-3276-0162
Aysu SelçukAnkara University, Faculty of Pharmacy, Department of Clinical Pharmacy, Ankara, Türkiye.ORCID 0000-0001-6424-7457
Şahin EyüpoğluAnkara University, Faculty of Medicine, Department of Nephrology, Ankara, Türkiye.ORCID 0000-0002-8009-6262
Şehsuvar ErtürkAnkara University, Faculty of Medicine, Department of Nephrology, Ankara, Türkiye.ORCID 0000-0002-7437-318X
Arif Tanju ÖzçelikayAnkara University, Faculty of Pharmacy, Department of Pharmacology, Ankara, Türkiye.ORCID 0000-0001-9142-9061
Ankara University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: This study aimed to identify the prevalence of potentially inappropriate medication use (PIMU) in adults above the age of 65 with chronic kidney disease (CKD) according to the American Geriatric Society Beers Criteria (Beers), Screening Tool of Older People's Potentially Inappropriate Prescriptions Criteria (STOPP) and medication appropriateness index (MAI) 30 criteria and to compare them to justify their use in this specific patient group. Materials and Methods: This was a retrospective and descriptive study conducted between October 1 Results: Among 269 patients discharged from the hospital during the study period, 100 of them were eligible for the study. The mean age was 73.3 ± 6.9 years and 51.9% of them were male. The prevalence of 35 PIMU was 91%, 42%, and 70% according to the Beers, STOPP, and MAI criteria, respectively. There was a statistically significant difference in terms of prevalence among 3 criteria ( Conclusion: The prevalence of PIMU was high among older adults with CKD at discharge according to these criteria. To improve the prescriptions after hospital discharge, it is considered appropriate to use Beers criteria under guidance of a clinical pharmacist.

Indexed as

chronic kidney diseaseolder adultsPotentially inappropriate medication use

Identifiers

PMID35775387
PMCPMC9254095
OpenAlexW3204662415

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.